Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

ANGO AngioDynamics, Inc.
$11.17 2.62% +0.29
Notify me if price changes either direction
Interactive Brokers Logotype

Buy ANGO stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 448.0M
Enterprise value 419.4M
Trailing PE 41.399998
Forward PE -99.090904
PEG Ratio -0.97854540727273
Enterprise to EBITDA -2796.143
Enterprise to revenue 1.365
Price to book MRQ 2.5701485
Price to sales TTM 1.4619614

Financials

Fiscal Year Ends 2025-05-31
Most Recent Quarter (MRQ) 2025-11-30
Revenue (TTM) 307.3M
EBITDA 15.1M
Diluted EPS TTM -0.67
Total Cash (MRQ) 41.6M
Current ratio (MRQ) 2.242
Operating Cash Flow (TTM) -5601000

ANGO trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent ANGO News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.